发明名称 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
摘要 Method and compositions for treating a patient having a neurological disease or disorder, such as stroke, head trauma, spinal cord injury, spinal cord ischemia, ischemia- or hypoxia-induced nerve cell damage, epilepsy, anxiety, neuropsychiatric or cognitive deficits due to ischemia or hypoxia such as those that frequently occur as a consequence of cardiac surgery under cardiopulmonary bypass, or neurodegenerative diseases such as Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, or amyotrophic lateral sclerosis (ALS).
申请公布号 US6017965(A) 申请公布日期 2000.01.25
申请号 US19960763480 申请日期 1996.12.11
申请人 NPS PHARMACEUTICALS, INC. 发明人 MUELLER, ALAN L.;BALANDRIN, MANUEL F.;VANWAGENEN, BRADFORD C.;MOE, SCOTT T.;DELMAR, ERIC G.;ARTMAN, LINDA D.;BARMORE, ROBERT M.;SMITH, DARYL L.
分类号 A61K31/135;A61K31/136;A61K31/137;A61K31/138;A61K31/155;A61K31/165;A61K31/295;A61K31/381;A61K31/40;A61K31/4409;A61K31/4462;A61K31/4465;C07C201/14;C07C211/27;C07C211/28;C07C211/29;C07C211/40;C07C211/42;C07C211/54;C07C211/55;C07C215/28;C07C215/54;C07C217/10;C07C217/48;C07C217/58;C07C217/60;C07C217/62;C07C233/11;C07C233/13;C07C233/22;C07C235/34;C07C237/06;C07C237/22;C07C257/14;C07C279/14;C07D207/08;C07D207/12;C07D207/20;C07D209/42;C07D211/18;C07D213/30;C07D213/32;C07D213/38;C07D231/20;C07D333/20;(IPC1-7):A61K31/135 主分类号 A61K31/135
代理机构 代理人
主权项
地址